BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26685489)

  • 21. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
    Allen LV
    Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of United States Pharmacopeia chapter 797: results of a national survey.
    Candy TA; Schneider PJ; Pedersen CA
    Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 26. Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy.
    Civen R; Vugia DJ; Alexander R; Brunner W; Taylor S; Parris N; Wasserman R; Abbott S; Werner SB; Rosenberg J
    Clin Infect Dis; 2006 Oct; 43(7):831-7. PubMed ID: 16941362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 28. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
    Kastango ES; Bradshaw BD
    Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
    [No Abstract]   [Full Text] [Related]  

  • 29. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
    Kastango ES;
    Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basics of compounding sterile preparations: nomenclature and considerations.
    Allen LV
    Int J Pharm Compd; 2014; 18(4):313-7. PubMed ID: 25474860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel.
    Allen LV
    Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units.
    Sidhu R
    Int J Pharm Compd; 2015; 19(4):307-10. PubMed ID: 26625567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Dec; 51(49):1109-12. PubMed ID: 12530707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "Negative" List.
    Allen LV
    Int J Pharm Compd; 2015; 19(4):311-3. PubMed ID: 26625568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP releases revision of chapter on sterile compounding: new version of USP chapter 797 emphasizes personnel.
    Thompson CA
    Am J Health Syst Pharm; 2008 Jan; 65(2):104, 111. PubMed ID: 18192250
    [No Abstract]   [Full Text] [Related]  

  • 38. Basics of sterile compounding: aseptic processing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(1):49-56. PubMed ID: 25902628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing medication errors with nimodipine by compounding proper dosage forms.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):364-8. PubMed ID: 24459780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.